Cognitive Impairment

In insurance, cognitive impairment refers to a condition that affects an individual's ability to think, reason, or remember. Cognitive impairment can result from a variety of conditions, such as dementia, Alzheimer's disease, or traumatic brain injury. Here are some key features of cognitive impairment in insurance:

  • Cognitive impairment is a condition that affects an individual's ability to think, reason, or remember.

  • Cognitive impairment can be caused by a variety of factors, such as dementia, Alzheimer's disease, or traumatic brain injury.

  • In insurance, cognitive impairment is often used as a criterion for determining eligibility for long-term care benefits or disability benefits.

  • Insurance policies may define cognitive impairment differently, but typically require the impairment to be severe enough to prevent the individual from performing activities of daily living, such as bathing, dressing, and eating.

  • To qualify for benefits, individuals with cognitive impairment may be required to undergo cognitive testing or provide medical documentation of their condition.

For example, let's say that John has been diagnosed with Alzheimer's disease. His insurance policy includes a provision for long-term care benefits in the event that he develops a cognitive impairment. The policy defines cognitive impairment as a condition that prevents an individual from performing activities of daily living, such as bathing, dressing, and eating. To qualify for benefits, John may be required to undergo cognitive testing or provide medical documentation of his condition.

In summary, cognitive impairment in insurance refers to a condition that affects an individual's ability to think, reason, or remember. Insurance policies may use cognitive impairment as a criterion for determining eligibility for long-term care benefits or disability benefits, and typically require the impairment to be severe enough to prevent the individual from performing activities of daily living. To qualify for benefits, individuals with cognitive impairment may be required to undergo cognitive testing or provide medical documentation of their condition.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.